More Figures from This Paper

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

Figure 6

400 × 258px · 11,6 Kio

Source Paper

Effect of Bifidobacterium longum 35624 on disease severity and quality of life in patients with irritable bowel syndrome.

World journal of gastroenterology (2022)

PMID: 35317278

DOI: 10.3748/wjg.v28.i7.732

Cite This Figure

![Figure 6: Figure 6](https://pdfs.citedhealth.com/figures/35317278/364.png)

> Source: Jean-Marc Sabaté et al. "Effect of Bifidobacterium longum 35624 on disease severity and quality of life i." *World journal of gastroenterology*, 2022. PMID: [35317278](https://pubmed.ncbi.nlm.nih.gov/35317278/)

<figure>
  <img src="https://pdfs.citedhealth.com/figures/35317278/364.png" alt="Figure 6" />
  <figcaption>Figure 6. Figure 6<br>  Source: Jean-Marc Sabaté et al. "Effect of Bifidobacterium longum 35624 on disease severity and quality of life i." <em>World journal of gastroenterology</em>, 2022. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/35317278/">35317278</a></figcaption>
</figure>

Preuves associées

Bifidobacterium longum pour Irritable Bowel Syndrome (IBS)

Note B · 4 études